These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Significance of arterial blood pressure for the development of microalbuminuria and retinopathy in type I diabetes mellitus]. Watschinger B, Schnack C, Bruck S, Stelzer N, Gisinger C, Schernthaner G. Klin Wochenschr; 1988 Nov 01; 66(21):1074-8. PubMed ID: 3236757 [Abstract] [Full Text] [Related]
6. Progressive decline in renal function in diabetic patients with and without albuminuria. Tsalamandris C, Allen TJ, Gilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, Jerums G. Diabetes; 1994 May 01; 43(5):649-55. PubMed ID: 8168641 [Abstract] [Full Text] [Related]
7. Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Goetz FC, Jacobs DR, Chavers B, Roel J, Yelle M, Sprafka JM. Am J Epidemiol; 1997 Jan 15; 145(2):91-102. PubMed ID: 9006305 [Abstract] [Full Text] [Related]
8. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Laffel LM, McGill JB, Gans DJ. Am J Med; 1995 Nov 15; 99(5):497-504. PubMed ID: 7485207 [Abstract] [Full Text] [Related]
9. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy. Holdaas H, Hartmann A, Berg KJ, Langberg H, Blystad L, Fauchald P. J Intern Med; 1995 Jan 15; 237(1):63-71. PubMed ID: 7830033 [Abstract] [Full Text] [Related]
12. Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study. Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, Rigamonti G, Spezia R, Crepaldi G. Diabetologia; 1994 Oct 15; 37(10):1015-24. PubMed ID: 7851680 [Abstract] [Full Text] [Related]
17. Diurnal variation in glomerular charge selectivity, urinary albumin excretion and blood pressure in insulin-dependent diabetic patients. Hansen PM, Goddijn PP, Kofoed-Enevoldsen A, van Tol KM, Bilo HJ, Deckert T. Kidney Int; 1995 Nov 03; 48(5):1559-62. PubMed ID: 8544414 [Abstract] [Full Text] [Related]
18. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int; 1995 Jun 03; 47(6):1703-20. PubMed ID: 7643540 [Abstract] [Full Text] [Related]